CLINICAL_TRIALS
research
· 2025-04-23
Clinical Trial Update: Endocalyx in Treatment Resistent Hypertension [Phase 2]
Summary
This entry reports a Phase 2 clinical trial of Endocalyx for treatment-resistant hypertension that is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Treatment Resistant Hypertension | Phase 2 | Status: RECRUITING